Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% Glycopyrronium Bromide Cream in Adolescents With Severe Primary Axillary Hyperhidrosis
NCT05863104Phase 2Completed
- Sponsor
- Dr. August Wolff
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WO3979 in primary axillary hyperhidrosis (PAH), sponsored by Dr. August Wolff. Started Mar 2023; status: completed.
02
Drugs
WO3979
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT05863104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863104.